Isolated Mediastinal Myeloid Sarcoma Successfully Treated with Chemoradiotherapy Followed by Unrelated Allogeneic Stem Cell Transplantation
スポンサーリンク
概要
- 論文の詳細を見る
A 22-year-old man was diagnosed with isolated mediastinal myeloid sarcoma which radiologically mimicked primary mediastinal lymphoma. Despite administration of standard remission induction chemotherapy with daunorubicin and cytarabine, and three cycles of intensive high-dose cytarabine-based consolidation, chemo-resistant hypermetabolic lesions were persistently detected in the highest mediastinum and in the supraclavicular area. However, complete remission and long-term survival were achieved by curative radiotherapy followed by unrelated allogeneic stem cell transplantation.
- 社団法人 日本内科学会の論文
著者
-
Lee Gyeong-won
Division Of Hematology And Oncology Department Of Internal Medicine School Of Medicine Gyeongsang Na
-
Ahn Jong-hwa
Division Of Hematology And Oncology Department Of Internal Medicine School Of Medicine Gyeongsang Na
-
Sun Suh
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Jo Yun-Won
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Hyun Min
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Mi Lee
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Song Haa-Na
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Kang Yeojin
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Kim Hosu
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Hun Lee
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Cheon Yun-Hong
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Jin Kim
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
-
Lee Gyeong-Won
Division of Oncology and Hematology Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Korea
関連論文
- ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy
- Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma : organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study
- Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab : Consortium for Improving Survival of Lymphoma (CISL) study
- Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer
- Isolated Mediastinal Myeloid Sarcoma Successfully Treated with Chemoradiotherapy Followed by Unrelated Allogeneic Stem Cell Transplantation
- PRASFIT-ACS: Important Evidence Against a "One-Guideline-Fits-All-Races" Approach to Antiplatelet Therapy